What is Pine Pharmaceuticals?
Pine Pharmaceuticals operates as a premier 503B outsourcing facility, providing essential compounded and repackaged pharmaceutical solutions. The company maintains a state-of-the-art, FDA-registered manufacturing environment, ensuring compliance with stringent safety and quality standards. Their diverse product portfolio, which includes intraocular injections, combination drops, and specialized IV bags, addresses the complex needs of ophthalmology, otolaryngology, and surgical practices. Beyond standard manufacturing, the firm distinguishes itself through collaborative partnerships with research organizations, facilitating the development of custom compounded solutions for clinical trials and specialized medical projects. This dual focus on high-volume production and bespoke clinical support establishes Pine Pharmaceuticals as a vital infrastructure partner for modern healthcare providers.
How much funding has Pine Pharmaceuticals raised?
Pine Pharmaceuticals has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Pine Pharmaceuticals
PPP
Public-Private Partnership
What's next for Pine Pharmaceuticals?
With the recent capital deployment, Pine Pharmaceuticals is poised to enhance its technological infrastructure and broaden its reach within the specialty medicine market. The strategic roadmap likely involves optimizing supply chain efficiencies and increasing the throughput of its FDA-registered facilities to accommodate a growing client base. Furthermore, the company is expected to deepen its involvement in clinical research, leveraging its manufacturing expertise to support the next generation of therapeutic developments. By prioritizing patient safety and regulatory compliance, Pine Pharmaceuticals is set to maintain its competitive advantage, potentially exploring new therapeutic areas or expanding its service offerings to further integrate into the clinical trial ecosystem. This phase of growth is critical for cementing the company's status as a leader in the pharmaceutical outsourcing industry.
See full Pine Pharmaceuticals company page
